Table I.
miR-133a | YES1 | |||||||
---|---|---|---|---|---|---|---|---|
Characteristics | Cases | High | Low | P-value | Cases | High | Low | P-value |
Age (years) | 0.256 | 0.325 | ||||||
≥60 | 30 | 12 | 18 | 31 | 22 | 9 | ||
<60 | 22 | 5 | 17 | 21 | 16 | 5 | ||
Sex | 0.235 | 0.301 | ||||||
Male | 32 | 9 | 23 | 33 | 24 | 9 | ||
Female | 20 | 8 | 12 | 19 | 14 | 5 | ||
Tumor size (mm) | 0.082 | 0.073 | ||||||
≤3 | 35 | 9 | 26 | 36 | 28 | 8 | ||
>3 | 17 | 8 | 9 | 16 | 10 | 6 | ||
Lymph nodes metastasis | 0.048a | 0.032a | ||||||
Yes | 12 | 5 | 7 | 11 | 5 | 6 | ||
No | 40 | 12 | 28 | 41 | 33 | 8 | ||
Tumor stage | 0.045a | 0.033a | ||||||
I–II | 41 | 11 | 30 | 39 | 31 | 8 | ||
III–IV | 11 | 6 | 5 | 13 | 7 | 6 |
Statistical analyses were performed by the χ2 test.
P<0.05, indicates significant difference. miR-133a, microRNA-133a; NSCLC, non-small cell lung cancer.